Browsing Tag
CDMO
40 posts
Oxford Biomedica (LSE: OXB) expands US manufacturing base with Durham viral vector facility buy
Find out how Oxford Biomedica’s new US viral vector facility strengthens its CDMO leadership and growth trajectory.
Québec and Ottawa unite to fund Delpharm’s Boucherville upgrade for hospital drug security
Find out how Delpharm’s C$220M investment is transforming its Boucherville plant into Canada’s sterile injectable powerhouse.
Torrent Pharmaceuticals to acquire J. B. Chemicals from KKR in INR 25,689 Cr deal: M&A to strengthen CDMO, IPM presence
Torrent Pharmaceuticals to acquire JB Pharma from KKR in INR 25,689 crore deal, followed by merger; aims to expand CDMO and India chronic segment leadership.
AtomVie Global Radiopharma partnering with TerraPower Isotopes to secure actinium-225 for global cancer therapy development
AtomVie Global Radiopharma signs agreement with TerraPower Isotopes to secure actinium-225 supply, aiming to advance CDMO-based cancer radiotherapies.
Glenmark Life Sciences is now Alivus Life Sciences: What this means for the pharma industry
Glenmark Life Sciences Limited, a prominent name in the pharmaceutical industry, has officially rebranded as Alivus Life Sciences…
Suven Pharmaceuticals acquires majority stake in NJ Bio, strengthens US presence
Suven Pharmaceuticals Limited, a technology-focused contract development and manufacturing organisation (CDMO), has announced the acquisition of a controlling…
Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing…
Piramal Pharma posts robust Q2 growth, expands Lexington facility to meet demand
Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635) has reported strong growth for the second quarter (Q2) and…
Glenmark Life Sciences’ Q1FY25 results shock industry with 9.7% revenue surge
Glenmark Life Sciences Limited (BSE: 543322, NSE: GLS), a prominent player in the pharmaceutical industry, has announced impressive…
Lupin Limited appoints Abdelaziz Toumi as CEO of new subsidiary
Global pharmaceutical giant, Lupin Limited, announced the appointment of Abdelaziz Toumi (commonly known as Abdel) as the Chief…